Medical AI Alliance
← Company Index
Medical DevicesKONEX 354390158 approvals4 trials

BASKHANBIOPharma Inc.

Official website

Founded 1986, KONEX-listed since 2022, BASKHANBIOPharma makes drugs and medical devices for use before and after surgery.

As of 2026-10-10, BASKHANBIOPharma Inc. has 6 Korean MFDS device approvals, 152 Korean MFDS drug approvals on record (counted by the MAA Company Index from its own matching of public databases).

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

BASKHANBIOPharma Inc. was founded in 1986 as Hanbul Pharmaceutical Co., listed on KONEX in 2022, and took its current name after LegoChem BioSciences acquired it in 2015 (renaming it LegoChem Pharma) and it merged with Medizone Co. in 2020. BAS in its English name stands for 'Before After on Surgery,' reflecting its core business of manufacturing and selling prescription and over-the-counter drugs and medical devices used before, during, and after surgery. The company obtained pharmaceutical manufacturing GMP in 2017 and medical device manufacturing GMP in 2020, and plans to expand its portfolio with non-reimbursed drugs, injectables, and hemostatic agents to increase operating profit.

Regulatory approvals

data.go.kr

152 Korean MFDS drug approvals · 1986–2026 / 6 Korean MFDS device approvals · 2018–2023

  • MFDS drugTrien Tab.2026-08-25
    Drug · OTC · Notification202602459
  • MFDS drugDiabelin Tab.2026-08-13
    Drug · OTC · Notification202602371
  • MFDS drugCelvadi Tab.2026-04-21
    Drug · OTC · Notification202601150
  • MFDS drugDikarec Alfa Tab. 1μg2026-04-01
    Drug · OTC · Notification202600927
  • MFDS drugVitapulse Tab.2025-12-09
    Drug · OTC · Notification202503210
  • MFDS drugDikarec D Plus Tab.2025-12-02
    Drug · OTC · Notification202503148
  • MFDS drugPanteol Cream2025-08-18
    Drug · OTC · Notification202502135
  • MFDS drugBerota A Tab.2025-07-30
    Drug · OTC · Notification202501990
  • MFDS drugTeravita F Soft Cap.2025-06-12
    Drug · OTC · Notification202501440
  • MFDS drugPowervita F Soft Cap.2025-04-30
    Drug · OTC · Notification202501058
  • MFDS drugLergyperine Tab.2025-04-29
    Drug · OTC · Notification202501032
  • MFDS drugCalandy Tab.2025-03-31
    Drug · OTC · Notification202500732
Show 68 more
  • MFDS drugFurphen M Tab.2025-01-15
    Drug · OTC · Notification202500121
  • MFDS drugFurphen F Tab.2025-01-15
    Drug · OTC · Notification202500122
  • MFDS drugDikarec Max Tab.2024-12-12
    Drug · OTC · Notification202402944
  • MFDS drugLupien Eve Soft Cap.2024-11-11
    Drug · OTC · Notification202402670
  • MFDS drugGinkgo Tab. 240mg2024-11-11
    Drug · OTC · Notification202402669
  • MFDS drugRisbium Tab.2024-10-07
    Drug · OTC · Notification202402385
  • MFDS drugMyall Tab.2024-10-02
    Drug · OTC · Notification202402367
  • MFDS drugWon Line Tab.2024-09-19
    Drug · OTC · Notification202402252
  • MFDS drugWon Line Semi Tab.2024-09-19
    Drug · OTC · Notification202402253
  • MFDS drugMelatry Tab.2024-08-30
    Drug · OTC · Notification202402098
  • MFDS drugLilexa S Tab.2024-05-29
    Drug · OTC · Notification202401338
  • MFDS drugSsakfreen Susp.2023-06-21
    Drug · OTC · Notification202301911
  • MFDSEndotherapy cannula, single-use2023-04-26
    Product approval · Class 2제인 23-4674 호
  • MFDS drugTalus Cream2023-04-20
    Drug · OTC · Notification202301297
  • MFDSEndotherapy cannula, single-use2023-04-19
    Product approval · Class 2제인 23-4645 호
  • MFDS drugTomuse Soft Cap.2023-04-13
    Drug · OTC · Notification202301227
  • MFDS drugMysok Tab.2023-03-29
    Drug · OTC · Notification202301043
  • MFDS drugL-carec Sol.2022-12-23
    Drug · OTC · Notification202204616
  • MFDS drugViDkhan Inj. (Cholecalciferol)2022-10-12
    Drug · Prescription · Notification202203815
  • MFDS drugBrikhan Inj. (Sugammadex sodium)2022-07-19
    Drug · Prescription · Approval202202969
  • MFDS drugMaynol Tab.2022-01-03
    Drug · OTC · Notification202200014
  • MFDSGraft/prosthesis, biomaterial2021-11-15
    Product approval · Class 4제허 21-907 호
  • MFDS drugMay-Q Tab.Revoked2021-06-23
    Drug · OTC · Notification202104806
  • MFDS drugL-camin Tab.2021-06-03
    Drug · OTC · Notification202104347
  • MFDS drugHepabeat D Soft Cap.2021-05-07
    Drug · OTC · Notification202103714
  • MFDS drugMaysen Tab.Revoked2021-03-09
    Drug · OTC · Notification202102170
  • MFDS drugAlmitin Plus Tab.2020-09-15
    Drug · OTC · Notification202006366
  • MFDS drugLupien Soft Cap.2020-07-29
    Drug · OTC · Notification202005496
  • MFDSDressing, adhesion barrier2020-04-03
    Product approval · Class 3제허 20-249 호
  • MFDS drugTopamak Tab. 25mg2020-01-03
    Drug · Prescription · Approval202000046
  • MFDS drugAlmitangel Tab.2019-11-07
    Drug · OTC · Notification201907790
  • MFDS drugAnerwell Tab.2019-10-18
    Drug · OTC · Notification201907340
  • MFDS drugLosatine Tab. 50mgRevoked2019-08-19
    Drug · Prescription · Approval201905844
  • MFDS drugAlbichem Tab.Revoked2019-07-02
    Drug · Prescription · Approval201904508
  • MFDS drugL-carec Tab.2019-06-25
    Drug · OTC · Notification201904337
  • MFDS drugFurphen Tab.Revoked2019-06-12
    Drug · OTC · Notification201903830
  • MFDS drugSowaen Tab.2019-06-04
    Drug · OTC · Notification201903734
  • MFDS drugRetova Tab. 10mg2019-05-16
    Drug · Prescription · Approval201903183
  • MFDS drugBaflozine Cap.2019-05-16
    Drug · Prescription · Approval201903186
  • MFDS drugRetova Tab. 20mg2019-04-30
    Drug · Prescription · Approval201902796
  • MFDS drugEviehill Tab.Revoked2019-04-29
    Drug · Prescription · Approval201902748
  • MFDSEndoscopic trocar, single use2019-04-25
    Product approval · Class 2제인 19-4320 호
  • MFDS drugFinasterine Tab. 5mg2019-03-29
    Drug · Prescription · Approval201901926
  • MFDS drugReito Tab. 50mgRevoked2019-03-26
    Drug · Prescription · Approval201901790
  • MFDS drugCebrec Cap. 100mg2019-03-25
    Drug · Prescription · Approval201901768
  • MFDS drugMoreable Tab. 1mg2019-03-11
    Drug · Prescription · Approval201901476
  • MFDS drugDikarec Tab.2019-03-06
    Drug · OTC · Notification201901368
  • MFDS drugDucla Tab. 375mgRevoked2019-02-20
    Drug · Prescription · Approval201901047
  • MFDS drugDucla Duo Tab. 500mgRevoked2019-02-20
    Drug · Prescription · Approval201901051
  • MFDS drugTreco Tab.Revoked2019-02-14
    Drug · OTC · Notification201900930
  • MFDS drugPowerssen Soft Cap.2019-01-30
    Drug · OTC · Notification201900736
  • MFDS drugBistar Tab.2018-11-13
    Drug · OTC · Notification201804495
  • MFDSAbrasive deviceRevoked2018-11-09
    Product approval · Class 1제신 18-1512 호
  • MFDS drugMedicon 600 Tab.2018-08-01
    Drug · OTC · Notification201803183
  • MFDS drugAlleon Tab.2018-07-12
    Drug · Prescription · Approval201802900
  • MFDS drugLosatine Plus F Tab.2018-06-22
    Drug · Prescription · Approval201802623
  • MFDS drugNorvaforce Tab.2018-06-15
    Drug · Prescription · Approval201802475
  • MFDS drugZembio Cap.2018-06-05
    Drug · OTC · Notification201802335
  • MFDS drugBonbaro inj. (Ibandronate sodium monohydrate)2018-04-27
    Drug · Prescription · Notification201801801
  • MFDS drugVitilec Cap.2018-02-20
    Drug · OTC · Notification201800864
  • MFDS drugFerro-Q Cap.2018-02-08
    Drug · OTC · Notification201800754
  • MFDS drugThiuracil Tab.2018-01-11
    Drug · Prescription · Approval201800174
  • MFDS drugDamycin Cap. 300mg2017-10-26
    Drug · Prescription · Notification201707609
  • MFDS drugOpalec Tab.2017-07-19
    Drug · Prescription · Approval201705763
  • MFDS drugLosatine Tab. 100mg2017-06-29
    Drug · Prescription · Approval201704862
  • MFDS drugPowerking Soft Cap.2017-05-01
    Drug · OTC · Notification201702265
  • MFDS drugLerica Cap. 150mg2017-04-27
    Drug · Prescription · Approval201702148
  • MFDS drugLerica Cap. 75mg2017-04-27
    Drug · Prescription · Approval201702149

Showing the 80 most recent of 158 records.

Clinical trials

data.go.kr

4 MFDS clinical trial authorisations · 2019–2020 (Bioequivalence 4)

  • Bioequivalence레페리손정(에페리손염산염)2020-03-18

    2 trial sites

  • Bioequivalence레고렉스캡슐200밀리그램(세레콕시브)2019-08-19

    2 trial sites

  • Bioequivalence레고모틴정5밀리그램(모사프리드시트르산염수화물)2019-08-08

    2 trial sites

  • Bioequivalence레고켐콜린알포세레이트연질캡슐(콜린알포세레이트)2019-05-27

    2 trial sites

Patents

KIPRIS · applicant-matched

AI reads

MAA server logs · IP-verified
73
Times AI engines pulled BASKHANBIOPharma Inc.'s records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

0
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

73
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

9
live 0
Last 7 days
60
live 0
Last 30 days
73
live 0
All time
  • OpenAIOAI-SearchBot62
  • PerplexityPerplexityBot5
  • GoogleGoogleOther4
  • AnthropicClaudeBot2

Measured since Aug 27, 2026 · 4 AI engines · last read Oct 8, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for BASKHANBIOPharma Inc. and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview · products · R&D. Send us materials and we will add them

Companies approved for the same productsMedical Devices

Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.

BioPlus Co., Ltd2 shared

Founded in 2003 and KOSDAQ-listed in 2021, BioPlus develops HA-based bio medical devices and biopharmaceuticals using its proprietary MDM Technology platform.

WSI Co., Ltd.2 shared

Founded and KOSDAQ-listed in 2018, WSI distributes spine/joint devices and has expanded into medical robots and pharma via subsidiaries.

METABIOMED.CO.,LTD2 shared

KOSDAQ-listed medical device company manufacturing synthetic bioresorbable suture yarn and dental root canal filling materials.

PharmaResearch Co., Ltd.2 shared

KOSDAQ-listed medical device company producing PDRN pharmaceuticals, HA fillers, and Rejuran-branded cosmetics.

BNC KOREA, Inc.2 shared

Founded and listed on the KOSDAQ in 2016, BNC Korea is a biohealthcare company specializing in HA fillers, botulinum toxin, and dermo-cosmetics.

NUON CO., LTD.1 shared

KOSDAQ-listed healthcare company selling the Cissus weight-management ingredient and Sallimbaekseo household products.

Hanmi Pharm. Co., Ltd.1 shared

KOSPI-listed pharmaceutical company behind the combination drugs Amosartan (hypertension) and Rosuzet (dyslipidemia).

Hanmi Science Co.,Ltd1 shared

KOSPI-listed operating holding company of the Hanmi Pharm group, also running healthcare and pharmaceutical wholesale businesses.

JW SHINYAK CORPORATION1 shared

A pharmaceutical company supplying antifungal and urology drugs to clinics, co-marketing original drugs together with JW Pharmaceutical.

HUONS CO., LTD.1 shared

KOSDAQ-listed pharmaceutical and healthcare company producing lidocaine anesthetics and the Kynix hyaluronic-acid eye-drop line.

DongBang Medical Co., Ltd.1 shared

KOSDAQ-listed medical device maker producing disposable acupuncture needles, cupping cups, and hyaluronic acid dermal fillers.

Medy-Tox Inc.1 shared

Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition